Effects of PPAR.GAMMA. on hypertension, atherosclerosis, and chronic kidney disease-Reference-Cited by-同舟云学术

Effects of PPAR.GAMMA. on hypertension, atherosclerosis, and chronic kidney disease

Published:2010 Issue:10 Volume:57 Page:847-852
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Sugawara Akira¹,Uruno Akira²,Kudo Masataka³,Matsuda Ken³,Yang Chul Woo⁴,Ito Sadayoshi³

Affiliation:

1. Department of Advanced Biological Sciences for Regeneration, Tohoku University Graduate School of Medicine, Sendai, Japan

2. Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan

3. Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

4. Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/57/10/57_K10E-281/_pdf

Reference37 articles.

1. Peroxisome Proliferator-Activated Receptors: From Genes to Physiology

2. 2. Marchesi C, Schiffrin EL (2008) Peroxisome proliferator- activated receptors and the vascular system: beyond their metabolic effects. J Am Soc Hypertens 2: 227-238.

3. 3. Sarafidis PA, Lasaridis AN (2006) Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect. Am J Hypertens 19: 646-653.

4. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptor gamma and osteoprotegerin levels as an indicator and diagnostic predictor of endothelial dysfunction;Turkish Journal of Biochemistry;2023-11-27

2. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases;Frontiers in Pharmacology;2022-10-21

3. Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension;ACS Omega;2022-06-20

4. PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys;International Journal of Molecular Sciences;2021-09-28

5. In Vitro Cell Culture Models of Hyperoxaluric States: Calcium Oxalate and Renal Epithelial Cell Interactions;Crystals;2021-06-25